T36.7X2S Poisoning by antifungal antibiotics, systemically used, intentional self-harm, sequela

Name of the Condition

• Poisoning by antifungal antibiotics, systemically used, intentional self-harm, sequela

Summary

This condition represents the residual effects of intentional self-harm from poisoning by systemically administered antifungal antibiotics. It applies to cases where the initial harmful event has resulted in long-term consequences or chronic conditions. Documentation should specify the antifungal agent, the intentional nature of the exposure, and details of the sequela to ensure accurate coding.

Causes

Intentional self-harm may result from deliberate overdose or misuse of systemically used antifungal antibiotics. Adverse effects can stem from allergic reactions, drug interactions, or idiosyncratic responses. Underdosing may occur due to dosing errors, non-adherence, or inadequate prescription, leading to subtherapeutic levels.

Risk Factors

• Prior history of antifungal allergies or sensitivities.
• Polypharmacy increasing interaction risks.
• Renal or hepatic impairment affecting drug metabolism.
• Pediatric or geriatric populations with altered pharmacokinetics.
• Inadequate patient education on medication use.

Symptoms

• Gastrointestinal: Nausea, vomiting, diarrhea, abdominal pain.
• Allergic: Rash, urticaria, anaphylaxis.
• Systemic: Fever, hypotension, organ dysfunction (e.g., nephrotoxicity).
• Neurological: Dizziness, confusion, or seizures in severe cases.

Diagnosis

Diagnosis involves reviewing the patient’s history of intentional self-harm, identifying the specific antifungal agent involved, and assessing residual effects. Clinical evaluation may include laboratory tests to detect drug levels or organ damage, and imaging to evaluate long-term complications.

Treatment Options

Treatment focuses on managing sequela and preventing recurrence. This may include ongoing monitoring, rehabilitation, and psychological support. Medications to address residual symptoms or organ dysfunction may be prescribed, tailored to the patient’s specific needs.

Prognosis and Follow-Up

Prognosis depends on the severity of the initial poisoning and the nature of the sequela. Regular follow-up is essential to monitor for complications, adjust treatment, and provide ongoing support. Long-term outcomes may vary based on the extent of organ damage or psychological impact.

Complications

Potential complications include chronic organ dysfunction (e.g., renal or hepatic impairment), persistent neurological effects, or recurrent self-harm behaviors. Psychological sequelae, such as depression or anxiety, may also occur.

Lifestyle & Prevention

Preventive measures include proper medication storage, patient education on safe use, and access to mental health resources. Avoiding polypharmacy and monitoring for drug interactions can reduce risks. Regular follow-up with healthcare providers is recommended.

When to Seek Professional Help

Seek immediate medical attention if new or worsening symptoms occur, such as severe abdominal pain, difficulty breathing, or signs of organ failure. Ongoing psychological support should be sought if there are concerns about self-harm or mental health.

Tips for Medical Coders

Document the specific antifungal agent, the intentional nature of the self-harm, and the sequela in detail. Ensure the code aligns with the patient’s history and clinical findings. Verify that the sequela is directly related to the initial poisoning event to support accurate coding.